Methods borrowed from the textiles industry show promise for scaling up tissue engineering and making it cheaper.
Tissue engineering is a process that uses novel biomaterials seeded with stem cells to grow and replace missing tissues. When certain types of materials are used, the “scaffolds” that are created to hold stem cells eventually degrade, leaving natural tissue in its place. The challenge is creating enough of the material on a scale that clinicians need to treat patients.
Tissues could help patients suffering from wounds caused by diabetes and circulation disorders, patients in need of cartilage or bone repair, and women who have had mastectomies by replacing their breast tissue.
In typical tissue engineering approaches that use fibers as scaffolds, nonwoven materials are often bonded together using an electrostatic field. This process, called electrospinning, creates the scaffolds needed to attach to stem cells; however, large-scale production is not cost-effective.
“Electrospinning produces weak fibers, scaffolds that are not consistent and have pores that are too small,” says Elizabeth Loboa, dean of the University of Missouri College of Engineering.
“We can run our system for hours and create about a ten-inch diameter of scaffold material. Therefore, we sought to test methods that could standardize the process. The goal of ‘scaling up’ is to produce hundreds of meters of material that look the same, have the same properties and can be used in clinical settings.
“So, we investigated the processes that create textiles, such as clothing and window furnishings like drapery, to scale up the manufacturing process.”
Loboa and colleagues have published a pair of papers using three common textile creation methods—meltblowing, spunbonding, and carding—to determine if these methods would create the materials needed to mimic native tissue.
Meltblowing is a technique during which nonwoven materials are created using a molten polymer to create continuous fibers. Spunbond materials are made much the same way but the fibers are drawn into a web while in a solid state instead of a molten one. Carding involves the separation of fibers through the use of rollers, forming the web needed to hold stem cells in place.
The team tested these techniques to create polylactic acid (PLA) scaffolds, a Food and Drug Administration-approved material used as collagen fillers, seeded with human stem cells. They then spent three weeks studying whether the stem cells remained healthy and if they began to differentiate into fat and bone pathways, which is the goal of using stem cells in a clinical setting when new bone and/or new fat tissue is needed at a defect site.
Results show that the three textile manufacturing methods proved as viable if not more so than electrospinning.
“These alternative methods are more cost-effective than electrospinning,” Loboa says. “A small sample of electrospun material could cost between $2 to $5. The cost for the three manufacturing methods is between $.30 to $3.00; these methods proved to be effective and efficient. Next steps include testing how the different scaffolds created in the three methods perform once implanted in animals.”
The studies are published in Biomedical Materials and in Acta Biomaterialia, respectively. Loboa worked with Stephen A. Tuin, a recent doctoral graduate from her research group at the Joint Department of Biomedical Engineering at the University of North Carolina and NC State University (NCSU), and Behnam Pourdeyhimi of the NCSU College of Textiles.
The National Science Foundation, the National Institutes of Health, and the Nonwovens Institute all provided funding for the studies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
Source: University of Missouri